293 related articles for article (PubMed ID: 11417181)
41. [Antioxidative features of ambroxol--usefulness in COPD].
Nowak D
Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
[No Abstract] [Full Text] [Related]
42. Study on clinical properties and mechanisms of action of Petasites in bronchial asthma and chronic obstructive bronchitis.
Ziolo G; Samochowiec L
Pharm Acta Helv; 1998 Feb; 72(6):378-80. PubMed ID: 9556439
[No Abstract] [Full Text] [Related]
43. [Bisolvomycin and Bisolvon in the treatment of chronic bronchitis, bronchial asthma and bronchiectasis].
Mijusković B; Macanović J
Plucne Bolesti Tuberk; 1972; 24(3):229-33. PubMed ID: 4571639
[No Abstract] [Full Text] [Related]
44. A controlled trial of ambroxol in chronic bronchitis.
Guyatt GH; Townsend M; Kazim F; Newhouse MT
Chest; 1987 Oct; 92(4):618-20. PubMed ID: 3308343
[TBL] [Abstract][Full Text] [Related]
45. [The treatment of patients with nonspecific inflammatory lung diseases under outpatient conditions].
Nersesian ON; Gladkiĭ AV; Masterov GD; Bogatyreva EV; Golikova EV
Vrach Delo; 1989 Jun; (6):70-3. PubMed ID: 2781769
[TBL] [Abstract][Full Text] [Related]
46. Acebrophylline: an airway mucoregulator and anti-inflammatory agent.
Pozzi E
Monaldi Arch Chest Dis; 2007 Jun; 67(2):106-15. PubMed ID: 17695695
[TBL] [Abstract][Full Text] [Related]
47. Clinical trial with CO-1177: a preliminary report.
Mbuyamba P
Int J Clin Pharmacol Res; 1986; 6(2):119-21. PubMed ID: 3522442
[TBL] [Abstract][Full Text] [Related]
48. [Mechanisms of blood rheological disorders and their role in the progression of chronic obstructive bronchitis].
Danilov IP; Makarevich AE
Ter Arkh; 1985; 57(3):19-22. PubMed ID: 4002159
[TBL] [Abstract][Full Text] [Related]
49. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in patients with exacerbated chronic bronchitis].
Scillieri E
Boll Chim Farm; 1990; 129(10-11):68S-74S. PubMed ID: 2102705
[TBL] [Abstract][Full Text] [Related]
50. Do mucolytics help in chronic bronchitis and asthma?
Drug Ther Bull; 1984 Apr; 22(8):29-31. PubMed ID: 6714085
[No Abstract] [Full Text] [Related]
51. No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases.
Medici TC; Shang H; Grosgurin P; Berg P; Achermann R; Wehrli R
Bull Eur Physiopathol Respir; 1985; 21(6):477-83. PubMed ID: 3907738
[TBL] [Abstract][Full Text] [Related]
52. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
Fadda G
Minerva Med; 2001 Aug; 92(4):269-75. PubMed ID: 11535970
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation of a broncho-secretolytic in lung specialties with the help of a simple measuring method].
Wilde W
Arztl Forsch; 1966 Mar; 20(3):149-56. PubMed ID: 6014420
[No Abstract] [Full Text] [Related]
54. Plurichronocorticoid treatment of bronchial asthma and chronic bronchitis. Clinical and endocrino-metabolic evaluation.
Crepaldi G; Muggeo M
Chronobiologia; 1974 Sep; 1 Suppl 1():407-23. PubMed ID: 4471281
[No Abstract] [Full Text] [Related]
55. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.
Hothersall EJ; Chaudhuri R; McSharry C; Donnelly I; Lafferty J; McMahon AD; Weir CJ; Meiklejohn J; Sattar N; McInnes I; Wood S; Thomson NC
Thorax; 2008 Dec; 63(12):1070-5. PubMed ID: 18757458
[TBL] [Abstract][Full Text] [Related]
56. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
57. [Treatment of sore throat pain with ambroxol-containing lozenges. Results of a pharmacy supported patient questionnaire].
Gillissen A; Hinkel U
Med Monatsschr Pharm; 2005 Nov; 28(11):399-403. PubMed ID: 16309023
[No Abstract] [Full Text] [Related]
58. [The cellular immunity and cyclonucleotide level in the immunoregulatory cells of patients with bronchial asthma and chronic bronchitis].
Strigin VM; Kolesnikov AP
Ter Arkh; 1994; 66(1):72-5. PubMed ID: 7908463
[TBL] [Abstract][Full Text] [Related]
59. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
60. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
